At a glance
- Originator Merck & Co
- Class Antiasthmatics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 27 Feb 1997 No-Development-Reported for Asthma in USA (Unknown route)
- 25 Aug 1994 Preclinical development for Aspergillosis in USA (Unknown route)